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Introduction
A breast lymphoma is a rare malignancy and
presents either as a primary or secondary extranodal
disease [1]. The majority of patients diagnosed with
primary breast lymphomas are reported to have
intermediate-grade tumors, such as diffuse large B-cell
lymphomas [2]. Fewer studies are reported about
secondary breast lymphomas, which are even more
rare than primary breast lymphomas with an reported
incidence of 0.07% of all breast malignancies [1].
In this report, we represent a case of a secondary
breast lymphoma, which was first detected during 18F-
fluorodeoxyglucose-positron emission tomography/
computed tomography (18F-FDG PET/CT) as an
unexpected mass showing hypermetabolism, and then
found on ultrasonography (US).
Case Report
A 49-year-old woman had pain in the left buttock
and leg for 6 months. She did not have any other
medical history or symptoms in the breast. Computed
tomography (CT) and magnetic resonance image
(MRI) scans of the spine showed multiple enhancing
lesions on the 5th lumbar vertebra, the sacrum, and
the left iliac bone, and osteolytic lesions with soft
tissue infiltration in the left sacrum, which suggested
metastatic malignancy. For evaluation of the primary
site of malignancy, she underwent 18F-FDG PET/CT.
18F-FDG PET/CT scans showed focal increased 18F-
FDG uptake in multiple levels of vertebrae, the
sacrum, and the pancreas. In addition, two lesions of
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PET/CT Scan에서 발견된 유방 전이 림프종의 초음파 소견
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Breast lymphomas, either manifesting as a primary extranodal disease or sec-
ondary involvement, are a rare form of malignancy. Breast lymphomas can be visual-
ized as hypermetabolic lesions in 18F-fluorodeoxyglucose-positron emission tomogra-
phy/computed tomography (18F-FDG PET/CT) scans. Here, we describe a case of a
secondary breast lymphoma, detected with 18F-FDG PET/CT.
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focal increased uptake were seen in the left breast
(Fig. 1A and B). The standard uptake value (SUV) of
focal increased uptake in the left breast lesions were
198.3 and 190.7.
On a routine mammogram performed for evaluation
of the left breast lesion with increased uptake, there
were no visible masses, abnormal parenchymal
density, or calcifications (Fig. 1C). Ultrasonography
(US) showed two hypoechoic nodules with angular or
indistinct margins in the left outer central and left
lower outer quadrants, which were assessed as
category 4b, intermediate suspicious findings (Fig. 1D
and 1E; transverse and longitudinal images). The
lesion size, morphology, and location of the masses on
US were well correlated with those of increased
uptakes on 18F-FDG PET/CT.
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Fig. 1. Secondary B-cell lymphoblastic lymphoma of the breast in a 49-year-old woman.
A. PET-torso image shows focal increased 18F-FDG uptakes in multiple levels of the vertebrae and sacrum.
B. Fusion image shows two lesions with increased uptakes in the left breast.
C. A mammography (mediolateral oblique view) does not show specific abnormalities in either breast.
D, E. Ultrasonography shows two hypoechoic nodules with angular and indistinct margins in the left outer central and left lower
outer quadrants of the breast. They are assessed as intermediately suspicious for malignancy.
A US-guided 14-gauge core biopsy was performed
on the suspicious nodule in the left lower outer
quadrants. Biopsy specimens of the breast were
evaluated microscopically and immunohistochemi-
cally, including with CD99 and cytokeratin.
Microscopic examinations (Fig. 2A, hematoxylin and
eosin ×200) show extensive infiltration into the breast
parenchyma by lymphoblasts with atypical round to
oval-shaped nuclei. On immunohistochemical
staining, specimens were positive for CD99, and
negative for cytokeratin, suggestive of a B-cell
lymphoblastic lymphoma (Fig. 2B, C). Also, a CT-
guided biopsy on the sacral mass was performed.
Immunohistochemical stains of the specimen from the
sacrum were positive for TdT, CD99, CD10 and
CD79a, and negative for CD3 and S-100. These
findings are also suggestive of B-cell lymphoblastic
lymphoma.
Discussion
18F-FDG PET/CT is a glucose analog for which many
malignant tumors have an increased avidity, including
breast cancer [3]. To date, 18F-FDG PET/CT has been
demonstrated to be the most efficient method to
localize unknown primary tumors, with detection
rates between 24% and 53% [4]. Although the
diagnosis of primary cancer or the detection of
recurrence is definite only via histopathologic criteria,
18F-FDG PET/CT can accurately guide the tissue
sampling and improve the yield [3].
In women without a history of breast cancer, the
incidence of unexpected foci with hypermetabolic
activity on 18F-FDG PET/CT is reported to be
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Fig. 2. Secondary B-cell lymphoblastic lymphoma of the breast in
a 49-year-old woman.
A. Microscopic examination (hematoxylin and eosin ×200)
shows extensive infiltration into the breast parenchyma by
lymphoblasts with atypical round-to-oval-shaped nuclei. 
B, C. On immunohistochemical staining, specimens are positive
for CD99, and negative for cytokeratin.
1.1~1.4%, and of these, 20.8% prove to be malignant
tumors (breast cancer: 36% and metastasis: 67%) [5].
Because of this possibility, a biopsy should always be
performed at the hypermetabolic lesion. However, 18F-
FDG PET/CT-guided biopsies are not yet routine
procedures. So, US correlation is important for
histologic confirmation as a guidance modality. The
most common metastatic lesion detected on 18F-FDG
PET/CT is a malignant lymphoma [5]. Breast
lymphomas, either as a manifestation of primary
extranodal diseases, or as secondary involvement, are
rare malignancies [1]. Malignant lymphomas of the
breast are rare, mostly presenting as non-Hodgkin’s
lymphoma, which represent approximately 70-90%
of all breast lymphomas [7]. A B-lymphoblastic
lymphoma, as reported in our case, is a type of non-
Hodgkin’s lymphoma. The reported incidence of
primary breast lymphomas ranges from 0.04% to
0.5% of all breast malignancies [6]. Secondary breast
lymphomas are less well-studied in the literature than
primary breast lymphomas because secondary breast
lymphomas are so rare, with a reported incidence of
0.07% of all breast malignancies [2].
The radiologic features of breast lymphomas are
non-specific, and the diagnosis cannot be made solely
on the basis of radiological findings, since the
mammographic and US features may be
indistinguishable from those of other common breast
malignancies. Mammography usually demonstrates a
well-circumscribed mass with sharp or minimally
irregular margins and no calcifications [8]. US features
also vary, from well-defined to poorly defined, hypo-
to hyperechoic masses with or without focal or diffuse
involvement of the remaining breast [8]. Our case did
not show abnormal findings on a mammogram. On
US, hypoechoic nodules with angular or indistinct
margins were observed. It has been demonstrated that
no pathognomonic radiologic features exist for the
differential diagnosis between breast lymphoma and
carcinoma. A distinction between lymphoma and
carcinoma is important because these two
malignancies differ in treatment. Treatment for
lymphoma is chemotherapy, not surgery, which is
conversely the standard treatment for breast
carcinoma [1]. Therefore, histopathologic confirmation
is essential.
요 약
원발성 혹은 전이성 유방 림프종은 드물게 보고 되는 유
방의 악성 종양이다. 유방 림프종은 18F-FDG PET/CT에
서 대사항진을 보인다. 본 증례는 18F-FDG PET/CT 에서
발견된 유방의 전이 림프종의 예이다. 
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